Dl-3,4-dihydroxymandelic acid
| Title | Journal |
|---|---|
| Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach. | Drug metabolism and disposition: the biological fate of chemicals 20111101 |
| Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases. | Toxicology letters 20110425 |
| Investigation by imaging mass spectrometry of biomarker candidates for aging in the hair cortex. | PloS one 20110101 |
| A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats. | Basic & clinical pharmacology & toxicology 20060901 |
| 3,4-Dihydroxymandelic acid, a noradrenalin metabolite with powerful antioxidative potential. | Journal of agricultural and food chemistry 20021009 |
| Norepinephrine metabolism in neuron: dissociation between 3,4-dihydroxyphenylglycol and 3,4-dihydroxymandelic acid pathways. | Acta pharmacologica Sinica 20020101 |
| Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase. | Molecular pharmacology 20010201 |
| Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. | The Journal of biological chemistry 19990507 |